Clinical Trial Applications - Suspended: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Suspended | |
|---|---|---|---|---|---|
1. |
ECCT/23/10/02 | MATRIX-001 protocol A Phase I Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety, Pharmacokinetics, and Modeled Pharmacodynamics of a Vaginal Insert Containing Tenofovir Alafenamide and Elvitegravir |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR PHRD Thika |
Not recorded |
View |